SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BriaCell Reports Preclinical Bria-OTS+ Tumor-Cell Killing Across Three Cancer Types

BriaCell reported tumor-cell killing in preclinical studies of Bria-OTS+ across three cancer types.

Related stories